Treatments for MDS and Secondary AML, with Drs O. Odenike and D. Sallman

preview_player
Показать описание
Treatments for MDS and Secondary AML
Co-Chairs: Olatoyosi Odenike, MD, University of Chicago and David Sallman, MD, Moffitt Cancer Center

Drs. Odenike and Sallman discuss Highlights from the presentation, Treatments for MDS and Secondary AML, given during the 7th Annual International Bone Marrow Failure Scientific Symposium, July 15-17, 2020
Рекомендации по теме